Rich Haerle joined Needham & Co in November 2021, where he is currently Head of Healthcare Equity Capital Markets. Prior to his current role, he served as a Managing Director and Head of Healthcare Specialty Sales at Needham where he spent a majority of his time interacting and fostering relationships with institutional healthcare investors. Rich has over 20 years of financial experience, and previously worked at Morgan Stanley and Deutsche Bank in Healthcare Specialty Sales. He also spent over three years at a publicly traded biotech company as VP of Investor Relations and Corporate Strategy, where he was instrumental in expanding the company’s shareholder base. Rich began his career at Pfizer in 1997 and participated in the launch of multiple products in various therapeutic areas with a focus on CNS (Depression, Schizophrenia, Alzheimer’s Disease), Infectious Disease, and Pain/Inflammation. He holds three degrees from UCLA, including a Bachelor of Science in Biology, Master of Public Health in Healthcare Policy and Management, and a Master of Business Administration.